Enduring CE Webinar: Improving Asthma Care: An Update for Managed Care Achieving Optimal Outcomes

Published on: 

Improving Asthma Care: An Update for Managed CareAchieving Optimal Outcomes (Enduring Webinar)


Aidan A. Long, MD

Clinical Director, Allergy and Immunology

Massachusetts General Hospital

Aidan A. Long, MD has disclosed expert testimony for GlaxoSmithKline.

The planning staff from the University of Cincinnati, The American Journal of Managed Care, and the Pharmacy Times Office of Continuing Professional Education have no relevant financial relationships to disclose.

Grant Support:

This activity is supported by an educational grant from Merck & Co, Inc.


Asthma still exacts a severe national burden through patient morbidity and mortality, rising healthcare costs, and employee absenteeism. There is a need to improve the management of asthma to improve outcomes and alleviate the burden on the patient and healthcare system.

This CE/CME activity will provide managed care healthcare professionals an overview of the unmet needs in asthma, discuss the pharmacoeconomic implications of therapy as they relate to clinical outcomes, and identify strategies that can help improve patients and providers achieve asthma control.

Target Audience:

Medical directors, pharmacy directors, and other managed care professionals who oversee the care of patients with asthma.

Educational Objectives:


Upon completion of this educational activity, participants should be able to:

  • Describe the significance of unmet needs among people with asthma and elucidate contributing factors to poor asthma control
  • Discuss the pharmacoeconomics of asthma therapy as it relates to clinical outcomes
  • Identify strategies for improving asthma control

The contents of this CE activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Type of Activity: Application-based.

Fee: None.

Length of Webinar: One hour including pre-recorded question-and-answer session.

Original Release Date: May 25, 2011


Expiration Date: May 25,

This CE lesson is contained in the following video/webinar:

  • Asthma Therapeutic Options (WMV)
  • Asthma Therapeutic Options (MP4)

This CE lesson is contained in the following PDF slides:

  • Asthma Therapeutic Options (PDF)

Requirements to view this webinar:

The webinar requires a media player capable of viewing files in the WMV or MP4 video format, and/or Adobe Acrobat Reader for viewing the pdf.

Physician Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the University of Cincinnati. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.

Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacist Credit

Pharmacy Times Office of Continuing Professional Education

is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1 contact hour (0.1 CEU) under the ACPE universal program number 0290-9999-11-032-H01-P. The program is available for CE credit through May 25, 2012.

Professional Disclaimer:

The information in this presentation is intended for educational use and to stimulate professional discussion among colleagues. It should not be construed as legal advice. There is no way such a brief discussion of an issue or topic for educational or discussion purposes can adequately and fully address the multifaceted and often complex issues that arise in the course of professional practice. Moreover, statutes, regulations and court interpretations of the law can vary from jurisdiction to jurisdiction. It is always the best advice for a pharmacist to seek counsel from an attorney who can become thoroughly familiar with the intricacies of a specific situation and render advice in accordance with the full information.

How to Receive Credit:

After viewing the activity “Improving Asthma Care: An Update for Managed Care - Emerging Therapeutic Options for Asthma,” complete the program evaluation and select the 1 best answer to each of the posttest questions.

A statement of continuing education hours will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher.